Please login to the form below

Not currently logged in
Email:
Password:

CCC appoints David Kane as MD

Chandler Chicco Companies (CCC), part of inVentiv health, has appointed David Kane as managing director, Biosector 2 (B2), reporting to Fiona Hall

Chandler Chicco Companies (CCC), part of inVentiv health, has appointed David Kane as managing director, Biosector 2 (B2).

Kane will move to Biosector 2 from Ogilvy Healthworld where he held the role of global brand leader for Boehringer Ingelheim and was also a senior member of the global medical education team.

During his 14-year career in medical education, Kane has aimed to develop global brand leadership, 360 communication strategy development, integrated marketing campaign delivery and emerging market development.

Kane said: "Our goal is to ensure that every element of the marketing mix is working together to deliver the most impactful support of our clients' objectives. We will have an approach which is strong and flexible, and purpose-built to evolve quickly and easily with the environment in which we operate today, ensuring we always create the most effective solutions for our clients' needs."

Commenting on David's appointment, Fiona Hall, European operations director for CCC said: "We are thrilled to have David as the newest member of our senior team. As our clients look to redefine their business models in the face of mounting and multiple pressures, CCC has a duty to be at the forefront of formulating new services and ways to meet client needs. David's appointment is just one of the exciting steps we are taking to do this."

Additionally, Neil Beasley, formerly managing director of Biosector 2, will take on a newly formed strategic client services and development role, servicing the entire CCC network. He will work across all agencies to assess and meet the evolving strategic needs of our clients.

"We see the current challenging environment as a great opportunity to show how consultancies can evolve and adapt to meet a diverse range of client needs," Hall said

22nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics